Published in PLoS One on March 02, 2016
Evaluation of microRNA Expression in Patients with Herpes Zoster. Viruses (2016) 0.75
A Study of the Changes of T Helper 17 Cells and Regulatory T Cells in Herpes Zoster. Ann Dermatol (2017) 0.75
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol (2003) 15.65
THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS. Proc R Soc Med (1965) 10.85
Clinical practice: Herpes zoster. N Engl J Med (2013) 5.16
IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol (2001) 3.91
Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm (2005) 2.63
In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J Immunol (2006) 2.44
Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol (2011) 2.06
Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol (2003) 2.05
Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. J Allergy Clin Immunol (2010) 2.02
Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol (2010) 1.96
Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. FASEB J (2004) 1.62
The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer. Curr Opin Immunol (2008) 1.51
IL-12-independent Th1 polarization in human mononuclear cells infected with varicella-zoster virus. Eur J Immunol (2005) 1.04
Local immune responses and systemic cytokine responses in zoster: relationship to the development of postherpetic neuralgia. Clin Exp Immunol (2003) 1.00
Sensitivity and resistance to regulation by IL-4 during Th17 maturation. J Immunol (2011) 0.97
Effect of single nucleotide polymorphisms within the interleukin-4 promoter on aspirin intolerance in asthmatics and interleukin-4 promoter activity. Pharmacogenet Genomics (2010) 0.96
Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis. Arch Dermatol (1996) 0.95
Cytokine production in varicella-zoster virus-stimulated cultures of human blood lymphocytes. J Infect Dis (1998) 0.88
Study on the T-helper cell 1/2 cytokine profile in blister fluid of patients with herpes zoster and its clinical significance. J Dermatol (2011) 0.80
Plasma Level of IL-4 Differs in Patients Infected with Different Modern Lineages of M. tuberculosis. J Trop Med (2012) 0.80
Intrathecal increase of sphingosine 1-phosphate at early stage multiple sclerosis. Neurosci Lett (2010) 0.93
Depletion of plasma gelsolin in patients with tick-borne encephalitis and Lyme neuroborreliosis. Neurodegener Dis (2011) 0.81
Cerebrovascular Manifestations of Lyme Neuroborreliosis-A Systematic Review of Published Cases. Front Neurol (2017) 0.75
Relapsing-Remitting Severe Bickerstaff's Brainstem Encephalitis - Case Report and Literature Review. Pol J Radiol (2016) 0.75
Month of birth and level of insolation as risk factors for multiple sclerosis in Poland. PLoS One (2017) 0.75
YKL-40 as a potential biomarker and a possible target in therapeutic strategies of Alzheimer's disease. Curr Neuropharmacol (2017) 0.75